NanoAntibiotics acquires company developing medicines for liver cirrhosis complications: 5 notes

NanoAntibiotics acquired LAT Pharma.

Here are five notes:

1. LAT Pharma is an early-stage biotechnology company developing medicines to treat life-threatening complications of liver cirrhosis.

2. Earlier this year, LAT Pharma had a pre-investigational new drug meeting to discuss a submission for a novel therapy to treat ascites due to liver cirrhosis.

3. NanoAntibiotics acquired LAT Pharma in an all-stock, cashless deal.

4. Following the acquisition, the newly formed company will change its name to BioVie.

5. NanoAntibiotics is a development stage company focused on the discovery, development and commercialization of novel drug therapies.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast